Preliminary study on establishment of a VCR-resistant colon carcinoma cell line and its underlying mechanism of drug-resistance

Tumor

Volumn 29, Issue 1, 2009, Pages 31-34

  Li, Chang Long ^a,b   Liu, Jian Wen ^a   Sa, Xiao Ying ^b   Deng, Wan Li ^c   Xu, Jian Hua ^c   Fan, Zhong Ze ^c  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cell line, tumor; Colonic neoplasms; Drug resistance, neoplasm; Vincristine

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; MESSENGER RNA; MITOMYCIN; MULTIDRUG RESISTANCE PROTEIN 1; PROPIDIUM IODIDE; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL LEVEL; CELL SURFACE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; EXOCYTOSIS; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; FLUOROMETRY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 77953463833     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2009.01.007     Document Type: Article

References (12)

1. BURDEN C, ROSE D, DANIELS I R. Bowel cancer: the outcome is improving[J]. J R Soc Health, 2005,125(6):255-258.
2. GOLDBERG R M. Advances in the treatment of metastatic colorectal cancer[J]. Oncologist, 2005,10 (Suppl 3):40-48.
3. LUQMANI Y A. Mechanisms of drug resistance in cancer chemotherapy[J]. Med Princ Pract, 2005,14 (Suppl 1):35-48.
4. FERGUSON R E, JACKSON S M, STANLEY A J. Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma[J]. Int J Cancer, 2005,115(1):155e-163e.
5. KUWANO M, ODA Y, IZUMI H, et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance[J]. Mol Cancer Ther, 2004,3(11):1485-1492.
6. TSURUO H, IIDA S, TSUKAGOSHI Y, et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil[J]. Cancer Res, 1981, 41(5): 1967-1972.
7. CONSTABLE P A, LAWRENSON J G, DOLMAN D E, et al. P-glycoprotein expression in human retinal pigment epithelium cell lines[J]. Exp Eye Res, 2006, 83(1): 24-30.
8. BOHACOVA V, SULOVA Z, DOVINOVA I, et al. L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein [J]. Toxicol In Vitro, 2006, 20 (8):1560-1568.
9. KAVALLARIS M, TAIT A S, WALSH B J, et al. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells [J]. Cancer Res, 2001,61(15): 5803-5809.
10. COUSEIN E, BARTHELEMY C, POULLAIN S, et al. P-glycoprotein and cytochrome P450 3A4 involvement in risperidone transport using an in vitro Caco-2/TC7 model and an in vivo model[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2007, 31(4):878-886.
11. LAH L, KRAŠEVEC N, TRONTELJ P, et al. High diversity and complex evolution of fungal cytochrome P450 reductase: Cytochrome P450 systems[J]. Fungal Genet Biol, 2008,45(4):466-458.
12. CASADO P, ZUAZUA-VILLAR P, DEL VALLE E, et al. Vincristine regulates the phosphorylation of the antiapoptotic protein HSP27 in breast cancer cells [J]. Cancer Lett, 2007, 247 (2): 273-282.